24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500
Regular Business Hours: Monday - Friday 8am - 5pm
Every 3rd Thursday of the Month - Extended Hours Until 7 pm

Medical Disorders
Resources
Basic InformationLookupsLatest News
Half of Americans Still Not Wearing Masks When Out in Public: PollFor Maximum Effectiveness, De-Stress and Get Healthy Before Your COVID ShotUK Prime Minister Says British COVID Variant May Be More DeadlyImmune System May 'Remember' Infections From Previous CoronavirusesYou're More Likely to Maintain Social Distance If Your Friends Do: StudyExercise Doesn't Boost Health If You Stay Obese, Study FindsEven When Cancer Is in Remission, Patients' Risks of Severe COVID RiseFor Rising Number of People, Obesity Is a Literal HeadacheSevere Allergic Reaction Extremely Rare With Pfizer COVID Vaccine: StudyWill Vaccines Work Against the New Coronavirus Variants?More Than 200,000 Americans Have LupusKids Highly Likely to Transmit Coronavirus to Others: StudyArthritis Drug Tocilizumab Flops as COVID-19 TreatmentBiden Unveils Details of National Pandemic Response PlanDental Practices Rebound as U.S. Dentists Look Forward to COVID VaccineAHA News: COVID-19 Registries Offer Lessons Beyond the CoronavirusCOVID-19 Ups Complication Risks During ChildbirthWhen ICUs Near Capacity, COVID Patients' Risk for Death Nearly DoublesGetting the COVID Vaccine? A Good Night's Sleep Will HelpAmerica Sees COVID Deaths Top 400,000, While New Variants Worry ScientistsNasal Spray COVID Vaccine Shows Promise in Animal TrialsFried Food a Big Factor in Heart Disease, StrokePromising Steps Toward Retinal Cell Transplants to Fight BlindnessDo You Socially Distance? Your Income Might MatterIf a Nursing Home Resident Gets a COVID Shot, Can Their Families Visit Them Now?Vision Problems? Here's a Guide to Which Specialist Is Right for YouShould Your Child Get a COVID Test?New Hope Against Diseases Marked by Progressive Scarring of Lung TissueAHA News: What Heart and Stroke Patients Should Know About COVID-19 VaccinesCOVID Pandemic Shortened U.S. Life Expectancy by More Than a YearShorter COVID Quarantine for College Athletes a Good Idea, Study FindsWhat Happened to the Flu This Year?3 Steps Could Nearly Eliminate COVID Infections on College Campuses: StudyPharmacy Chains Ready to Supply COVID-19 Vaccines to AmericansI've Already Had COVID-19, Do I Need the Vaccine?What Will COVID-19 Look Like Years From Now?First Computer Model of Entire COVID Virus Will Aid ResearchStopping Common Heart Meds Could Be Risky for Kidney PatientsU.S. COVID Vaccine Rollout Nears 1 Million Doses Per DayJohnson & Johnson's One-Dose COVID Vaccine Promising in Early TrialLockdowns' Benefits for Air Quality Weren't as Big as Thought: StudyPeople's 'Microbiomes' Might Influence COVID-19 Severity: StudyNew Insights Into How COVID-19 Damages the BrainCollege Campuses Are COVID 'Superspreaders,' Study FindsStuck at Home, Suffering With COVID? Experts Offer Guidance on CareCOVID Daily Death Toll Sets New U.S. Record, Soars Past 4,400AHA News: Registries Could Offer Insight Into COVID-19's Impact on College Athletes' HeartsResearch Reveals Why COVID Pneumonia Is More DeadlyPandemic Is Tied to Big Rise in U.S. Heart DeathsCommon Diabetes Meds Tied to Serious COVID-19 Complication
Questions and AnswersLinks
Related Topics

Diabetes

Thyroid Drug May Not Help After Heart Attack: Study

HealthDay News
by -- E.J. Mundell
Updated: Jul 21st 2020

new article illustration

TUESDAY, July 21, 2020 (HealthDay News) -- If a heart attack survivor also has an underactive thyroid, treating them with supplemental thyroid hormone probably won't help, new research shows.

The study found that use of the hormonal drug, called levothyroxine, didn't improve heart muscle function in heart attack patients diagnosed with "subclinical hypothyroidism" -- an underactive thyroid.

In fact, "screening for and subsequent treatment of subclinical hypothyroidism in patients who have had a heart attack to preserve or improve heart function is not justified," concluded the study's lead author, Salman Razvi. He's a consultant endocrinologist at Newcastle University and the Queen Elizabeth Hospital in Gateshead, U.K.

Mild or subclinical hypothyroidism -- which affects about 10% of adults -- means that the thyroid doesn't produce enough hormones.

Management of the condition is uneven because there's a lack of good evidence either for or against treatment, Razvi's team noted.

Dr. Satjit Bhusri is a cardiologist at Lenox Hill Hospital in New York City. He wasn't involved in the new research but said that, in the United States, guidelines for heart patients "generally do not recommend checking thyroid function unless there is an indication that's related to an arrhythmia [irregular heartbeat]."

The new British study included 46 heart attack survivors who had received levothyroxine and 49 who received a "dummy" placebo.

A year into treatment, heart function had improved in both groups, the researchers said, but there was no greater improvement in those who'd received levothyroxine.

The findings suggest that levothyroxine does not improve heart function in patients who've had a heart attack and is unlikely to be beneficial, Razvi's group said.

"The results of this trial will help clinicians reconsider offering treatment with levothyroxine to tens of thousands of patients with subclinical hypothyroidism worldwide," Razvi said in a university news release.

"To any patient who has had a heart attack and has been diagnosed with subclinical hypothyroidism, I would advise that they consult their [doctor] on whether levothyroxine is likely to be of benefit," he added. "The results of our trial suggest that all such patients should have their thyroid function rechecked after a few weeks. Treatment with levothyroxine should not be started routinely in such patients."

Dr. Benjamin Hirsh directs preventive cardiology at Northwell Health's Sandra Atlas Bass Heart Hospital in Manhasset, N.Y. Reviewing the new findings, he noted that "subclinical hypothyroidism is a milder form of hypothyroidism that's more common than true primary hypothyroidism." According to Hirsh, subclinical hypothyroidism "affects approximately 5% of the population."

Hirsh said that the study appears to recommend against the use of levothyroxine in heart attack patients with subclinical hypothyroidism. However, he also believes that the study's methodology provided only a "narrow scope" in measuring the benefit of treatment for the heart.

Also, "the sample size of the study is quite small, and it is difficult to make a strong conclusion either way given this limitation," Hirsh said.

The study was published July 21 in the Journal of the American Medical Association.

More information

The U.S. National Library of Medicine has more on hypothyroidism.